| Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization D Planas, D Veyer, A Baidaliuk, I Staropoli, F Guivel-Benhassine, ... Nature 596 (7871), 276-280, 2021 | 2121 | 2021 |
| Considerable escape of SARS-CoV-2 Omicron to antibody neutralization D Planas, N Saunders, P Maes, F Guivel-Benhassine, C Planchais, ... Nature 602 (7898), 671-675, 2022 | 1364 | 2022 |
| Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies D Planas, T Bruel, L Grzelak, F Guivel-Benhassine, I Staropoli, F Porrot, ... Nature medicine 27 (5), 917-924, 2021 | 729 | 2021 |
| Serum neutralization of SARS-CoV-2 Omicron sublineages BA. 1 and BA. 2 in patients receiving monoclonal antibodies T Bruel, J Hadjadj, P Maes, D Planas, A Seve, I Staropoli, ... Nature medicine 28 (6), 1297-1302, 2022 | 265 | 2022 |
| Reduced sensitivity of infectious SARS-CoV-2 variant B. 1.617. 2 to monoclonal antibodies and sera from convalescent and vaccinated individuals D Planas, D Veyer, A Baidaliuk, I Staropoli, F Guivel-Benhassine, ... Biorxiv, 2021.05. 26.445838, 2021 | 102 | 2021 |
| Multifunctional peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI H Benachour, A Sève, T Bastogne, C Frochot, R Vanderesse, ... Theranostics 2 (9), 889, 2012 | 97 | 2012 |
| Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization D Planas, N Saunders, P Maes, F Guivel-Benhassine, C Planchais, ... BioRxiv, 2021.12. 14.472630, 2021 | 92 | 2021 |
| Non polymeric nanoparticles for photodynamic therapy applications: recent developments R Chouikrat, A Seve, R Vanderesse, H Benachour, M Barberi-Heyob, ... Current medicinal chemistry 19 (6), 781-792, 2012 | 90 | 2012 |
| Effect of tenofovir disoproxil fumarate and emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: a pilot, randomized, open-label … JJ Parienti, T Prazuck, L Peyro-Saint-Paul, A Fournier, C Valentin, ... EClinicalMedicine 38, 2021 | 67 | 2021 |
| Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA. 2, BA. 4, and BA. 5 in patients receiving monoclonal antibodies T Bruel, K Stéfic, Y Nguyen, D Toniutti, I Staropoli, F Porrot, ... Cell Reports Medicine 3 (12), 2022 | 53 | 2022 |
| Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip T Prazuck, M Colin, S Giachè, C Gubavu, A Seve, V Rzepecki, ... PLoS One 15 (9), e0237694, 2020 | 52 | 2020 |
| Optical properties of functionalized nanodiamonds V Pichot, O Muller, A Seve, A Yvon, L Merlat, D Spitzer Scientific reports 7 (1), 14086, 2017 | 40 | 2017 |
| High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS‐CoV‐2 infection L Courtellemont, J Guinard, C Guillaume, S Giaché, V Rzepecki, A Seve, ... Journal of Medical Virology 93 (5), 3152-3157, 2021 | 37* | 2021 |
| Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study A Ursenbach, V Max, M Maurel, F Bani-Sadr, A Gagneux-Brunon, ... Journal of Antimicrobial Chemotherapy 75 (11), 3344-3348, 2020 | 30 | 2020 |
| Evaluation of performance of two SARS-CoV-2 Rapid whole-blood finger-stick IgM-IgG Combined Antibody Tests T Prazuck, M Colin, S Giachè, C Gubavu, A Seve, V Rzepecki, ... MedRxiv, 2020.05. 27.20112888, 2020 | 29 | 2020 |
| Duration of BA. 5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection D Planas, I Staropoli, F Porot, F Guivel-Benhassine, L Handala, M Prot, ... Med 3 (12), 838-847. e3, 2022 | 28 | 2022 |
| Real-time monitoring of photocytotoxicity in nanoparticles-based photodynamic therapy: a model-based approach H Benachour, T Bastogne, M Toussaint, Y Chemli, A Sève, C Frochot, ... PLoS One 7 (11), e48617, 2012 | 27 | 2012 |
| Study of the elaboration of HMX and HMX composites by the spray flash evaporation process V Pichot, A Seve, JE Berthe, F Schnell, D Spitzer Propellants, Explosives, Pyrotechnics 42 (12), 1418-1423, 2017 | 14 | 2017 |
| Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY. 4.2 N Saunders, D Planas, WH Bolland, C Rodriguez, S Fourati, J Buchrieser, ... EBioMedicine 77, 2022 | 12 | 2022 |
| Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting C Deschanvres, J Reynes, I Lamaury, D Rey, R Palich, F Bani-Sadr, ... Journal of Antimicrobial Chemotherapy 77 (1), 196-204, 2022 | 12 | 2022 |
